Frontiers in Immunology (Mar 2019)

BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection

  • Xueping Yu,
  • Xueping Yu,
  • Yijuan Zheng,
  • Richeng Mao,
  • Zhijun Su,
  • Jiming Zhang

DOI
https://doi.org/10.3389/fimmu.2019.00617
Journal volume & issue
Vol. 10

Abstract

Read online

B- and T-lymphocyte attenuator (BTLA) is an immune-regulatory receptor, similar to CTLA-4 and PD-1, and is mainly expressed on B-, T-, and all mature lymphocyte cells. Herpes virus entry mediator (HVEM)-BTLA plays a critical role in immune tolerance and immune responses which are areas of intense research. However, the mechanisms of the BTLA and the BTLA/HVEM signaling pathway in human diseases remain unclear. This review describes the research milestones of BTLA and HVEM in chronological order and their role in chronic HBV infection.

Keywords